Bitterman Robert J

Bitterman Robert J is listed in filings as Chairman at Phio Pharmaceuticals Corp.. This profile follows SEC Form 4 activity through Feb 6, 2026, including purchase activity. Recent filings connect the profile to Phio Pharmaceuticals Corp. (PHIO). The current snapshot covers public activity from Sep 13, 2024 to Feb 6, 2026. Reported amounts are shown as $5.2K to $5.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.